Cash flow LG Chem, Ltd.

Equities

A051910

KR7051910008

Commodity Chemicals

End-of-day quote Korea S.E. Other stock markets 17/04/2026			5-day change	1st Jan Change
360,000.00 ^KRW	+0.70%		+1.12%	+8.11%

04-14	Nomura Adjusts LG Chem's Price Target to KRW440,000 from KRW540,000, Keeps at Buy	MT
04-01	Frontier Medicines Corporation and Lg Chem Ltd Enter Exclusive Licensing Agreement for Fmc-220	CI

059cada3b1ca0aa0c.EAHgnvhnF1yVQYfh1uadBu68J7NnxcA_BVcttJBxf0c.f1Kj6YoEWzPDO8GO4YHJMavvRcAdjpJ9XDFo4f47SjBXao7HiBB1Kqwvtw

Published financial data: LG CHEM, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	42,655B	51,865B	55,250B	48,916B	45,932B
Total Revenues	42,655B	51,865B	55,250B	48,916B	45,932B
Cost of Goods Sold, Total	31,436B	41,878B	46,462B	41,377B	38,123B
Gross Profit	11,218B	9,986B	8,788B	7,539B	7,809B
Selling General & Admin Expenses, Total	5,525B	6,080B	5,777B	6,727B	6,609B
R&D Expenses	255B	385B	475B	577B	669B
Depreciation & Amortization - (IS)	245B	296B	362B	425B	528B
Amortization of Goodwill and Intangible Assets - (IS)	168B	230B	322B	373B	469B
Other Operating Expenses	-	-	-677B	-1,480B	-
Other Operating Expenses, Total	6,193B	6,991B	6,258B	6,622B	8,275B
Operating Income	5,025B	2,996B	2,529B	917B	-466B
Interest Expense, Total	-211B	-303B	-647B	-954B	-1,217B
Interest And Investment Income	83.12B	267B	341B	363B	331B
Net Interest Expenses	-128B	-35.8B	-306B	-591B	-886B
Income (Loss) On Equity Invest.	-511M	-46.22B	-33.31B	-24.86B	-118B
Currency Exchange Gains (Loss)	42.11B	-161B	466B	-537B	332B
Other Non Operating Income (Expenses)	243B	17.81B	79.77B	849B	2,152B
EBT, Excl. Unusual Items	5,182B	2,771B	2,736B	613B	1,014B
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	105B	-
Gain (Loss) On Sale Of Assets	-25.91B	-25.41B	-40.99B	-206B	-794B
Asset Writedown	-328B	-64.66B	-204B	-791B	-1,976B
Insurance Settlements	62.65B	132B	15.64B	21.88B	17.57B
Other Unusual Items	-	-	-8.18B	-10.05B	-41.54B
EBT, Incl. Unusual Items	4,891B	2,813B	2,498B	-268B	-1,780B
Income Tax Expense	1,236B	641B	433B	61.04B	16B
Earnings From Continuing Operations	3,655B	2,171B	2,066B	-329B	-1,796B
Earnings Of Discontinued Operations	299B	24.45B	-9.95B	843B	819B
Net Income to Company	3,954B	2,196B	2,056B	514B	-977B
Minority Interest	-284B	-350B	-718B	-1,205B	-842B
Net Income - (IS)	3,670B	1,845B	1,338B	-691B	-1,819B
Preferred Dividend and Other Adjustments	362B	182B	-	-	-
Net Income to Common Incl Extra Items	3,308B	1,663B	1,338B	-691B	-1,819B
Net Income to Common Excl. Extra Items	3,009B	1,639B	1,348B	-1,534B	-2,639B
Per Share Items
Net EPS - Basic	42.47K	21.34K	17.09K	-8.83K	-23.24K
Basic EPS - Continuing Operations	38.63K	21.02K	17.22K	-19.6K	-33.71K
Basic Weighted Average Shares Outstanding	77.89M	77.94M	78.28M	78.28M	78.28M
Net EPS - Diluted	42.47K	21.34K	17.09K	-8.83K	-23.24K
Diluted EPS - Continuing Operations	38.63K	21.02K	17.22K	-19.6K	-33.71K
Diluted Weighted Average Shares Outstanding	77.89M	77.94M	78.28M	78.28M	78.28M
Normalized Basic EPS	37.93K	17.72K	12.67K	-10.5K	-2.67K
Normalized Diluted EPS	37.93K	17.72K	12.67K	-10.5K	-2.67K
Dividend Per Share	12K	10K	3.5K	1K	2K
Payout Ratio	23.7	59.12	82.53	-53.17	-12.45
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	7,866B	6,392B	6,443B	5,578B	4,792B
EBITA	5,249B	3,287B	2,914B	1,391B	97.51B
EBIT	5,025B	2,996B	2,529B	917B	-466B
EBITDAR	-	-	6,597B	5,727B	-
Effective Tax Rate - (Ratio)	25.27	22.81	17.31	-22.77	-0.9
Total Current Taxes	-	-	706B	775B	-
Total Deferred Taxes	-	-	-300B	-700B	-
Normalized Net Income	2,955B	1,382B	992B	-822B	-209B
Interest Capitalized	45.89B	20.06B	91.12B	150B	198B
Interest on Long-Term Debt	-	-	737B	604B	-
Non-Cash Pension Expense	2.06B	-779M	-32.01B	-22.3B	-1.62B
Supplemental Operating Expense Items
Advertising Expense	39.06B	48.8B	78.48B	89.26B	71.11B
Marketing Expenses	20.95B	25.33B	31.23B	42.03B	25.59B
Selling and Marketing Expenses	1,909B	2,688B	2,101B	2,182B	2,163B
General and Administrative Expenses	28.37B	49.44B	62B	47.48B	35.62B
Research And Development Expense From Footnotes	255B	385B	2,033B	2,157B	669B
Net Rental Expense, Total	-	-	154B	149B	-
Imputed Operating Lease Interest Expense	-	-	47.97B	53.2B	-
Imputed Operating Lease Depreciation	-	-	106B	95.35B	-

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	3,761B	8,498B	9,085B	7,855B	9,900B
Short Term Investments	-	14.45B	57.11B	213B	1,003B
Trading Asset Securities, Total	64.58B	9.17B	-	-	-
Total Cash And Short Term Investments	3,825B	8,521B	9,142B	8,068B	10,903B
Accounts Receivable, Total	6,387B	7,450B	8,083B	8,166B	6,725B
Other Receivables	898B	556B	582B	861B	721B
Notes Receivable	65.27B	130B	-	-	-
Total Receivables	7,350B	8,136B	8,665B	9,027B	7,446B
Inventory	8,283B	11,881B	9,375B	8,847B	8,177B
Prepaid Expenses	466B	294B	-	-	217B
Other Current Assets, Total	484B	815B	1,677B	1,873B	1,805B
Total Current Assets	20,408B	29,647B	28,859B	27,816B	28,548B
Gross Property Plant And Equipment	41,029B	48,903B	60,490B	80,401B	86,578B
Accumulated Depreciation	-16,651B	-19,240B	-21,540B	-25,831B	-30,120B
Net Property Plant And Equipment	24,378B	29,663B	38,950B	54,570B	56,458B
Long-term Investments	1,165B	2,185B	2,295B	2,880B	2,610B
Goodwill	804B	786B	1,061B	801B	660B
Other Intangibles, Total	1,590B	1,860B	2,597B	2,779B	2,808B
Accounts Receivable Long-Term	67.06B	121B	130B	393B	384B
Loans Receivable Long-Term	331B	207B	9.89B	15.67B	12.94B
Deferred Tax Assets Long-Term	1,905B	2,166B	2,309B	2,866B	3,075B
Deferred Charges Long-Term	49.95B	43.66B	35.18B	38.63B	33.34B
Other Long-Term Assets, Total	437B	1,296B	1,220B	1,699B	6,472B
Total Assets	51,135B	67,974B	77,467B	93,858B	101,062B
Liabilities
Accounts Payable, Total	3,742B	4,756B	4,118B	3,682B	3,537B
Accrued Expenses, Total	700B	811B	477B	391B	328B
Short-term Borrowings	1,688B	1,402B	-	1,812B	3,275B
Current Portion of Long-Term Debt	1,717B	2,307B	6,978B	5,668B	8,341B
Current Portion of Leases	71.86B	95.08B	100B	141B	124B
Current Income Taxes Payable	958B	626B	45.3B	184B	569B
Unearned Revenue Current, Total	104B	149B	119B	90.94B	51.45B
Other Current Liabilities	6,081B	6,313B	6,553B	9,116B	9,912B
Total Current Liabilities	15,062B	16,460B	18,391B	21,086B	26,137B
Long-Term Debt	11,041B	11,866B	14,459B	18,981B	21,183B
Long-Term Leases	247B	295B	392B	774B	891B
Unearned Revenue Non Current	99.17B	225B	163B	103B	27.16B
Pension & Other Post Retirement Benefits	18.12B	19.47B	11.88B	9.79B	5.6B
Deferred Tax Liability Non Current	714B	839B	735B	433B	281B
Other Non Current Liabilities	743B	790B	2,377B	4,476B	5,431B
Total Liabilities	27,925B	30,493B	36,529B	45,862B	53,956B
Common Stock, Total	391B	391B	391B	391B	391B
Additional Paid In Capital	2,696B	11,363B	11,572B	11,569B	12,447B
Retained Earnings	18,092B	19,142B	19,651B	18,592B	16,999B
Treasury Stock	-18.01B	-270M	-270M	-270M	-270M
Comprehensive Income and Other	532B	554B	579B	2,732B	3,008B
Total Common Equity	21,694B	31,451B	32,193B	33,284B	32,846B
Minority Interest	1,516B	6,031B	8,746B	14,711B	14,260B
Total Equity	23,210B	37,481B	40,938B	47,995B	47,106B
Total Liabilities And Equity	51,135B	67,974B	77,467B	93,858B	101,062B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	77.91M	78.28M	78.28M	78.28M	78.28M
ECS Total Common Shares Outstanding	77.91M	78.28M	78.28M	78.28M	78.28M
Book Value / Share	278K	402K	411K	425K	420K
Tangible Book Value	19,299B	28,804B	28,535B	29,703B	29,377B
Tangible Book Value Per Share	248K	368K	365K	379K	375K
Total Debt	14,766B	15,965B	21,928B	27,376B	33,813B
Net Debt	10,940B	7,443B	12,786B	19,308B	22,911B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-26.93B	-599B	-483B	-207B	-429B
Debt Equivalent Oper. Leases	-	-	1,231B	1,188B	-
Minority Interest, Total (Incl. Fin. Div)	1,516B	6,031B	8,746B	14,711B	14,260B
Equity Method Investments, Total	535B	950B	1,006B	898B	353B
Account Code - Inventory Valuation	-	-	6	6	-
Inventories - Raw Materials, Total	2,307B	3,312B	3,682B	3,554B	3,371B
Inventories - Work In Process, Total	25.59B	32.44B	18.44B	26.23B	19.67B
Inventories - Finished Goods, Total	6,215B	8,944B	5,705B	5,329B	5,245B
Inventories - Others	-	-	342B	362B	-
Land - (BS)	1,852B	1,964B	2,010B	2,139B	2,122B
Buildings, Total	8,577B	10,378B	11,979B	15,422B	24,212B
Machinery, Total	25,742B	28,862B	31,764B	37,835B	41,578B
Full Time Employees	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	5.09B	5.02B	2.81B	2.44B	2.42B

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	3,670B	1,845B	1,338B	-691B	-1,819B
Depreciation & Amortization - CF	2,618B	3,105B	3,529B	4,188B	4,694B
Amortization of Goodwill and Intangible Assets - (CF)	223B	291B	385B	474B	563B
Depreciation & Amortization, Total	2,841B	3,396B	3,914B	4,662B	5,258B
Amortization of Deferred Charges, Total - (CF)	-	-	-	-	-
(Gain) Loss From Sale Of Asset	17.74B	25.05B	160B	-589B	822B
(Gain) Loss on Sale of Investments - (CF)	-	-	14.56B	-94.22B	-
Asset Writedown & Restructuring Costs	329B	64.66B	204B	791B	1,955B
(Income) Loss On Equity Investments - (CF)	-6.1B	-46.22B	-33.31B	24.86B	168B
Net Cash From Discontinued Operations	376B	29.76B	36.14B	882B	-
Other Operating Activities, Total	1,289B	571B	488B	579B	328B
Change In Accounts Receivable	-654B	-1,447B	-300B	618B	1,384B
Change In Inventories	-2,816B	-3,818B	2,965B	1,119B	618B
Change In Accounts Payable	289B	1,147B	-982B	-1,119B	-241B
Change in Other Net Operating Assets	174B	-1,199B	-268B	831B	-238B
Cash from Operations	5,510B	570B	7,536B	7,012B	8,234B
Capital Expenditure	-5,774B	-8,406B	-12,960B	-14,615B	-13,661B
Sale of Property, Plant, and Equipment	85.62B	82.16B	147B	122B	158B
Cash Acquisitions	386B	-8.99B	-702B	59.82B	1,767B
Divestitures	1M	49.78B	155B	793B	-
Sale (Purchase) of Intangible assets	-129B	-143B	-151B	-153B	-181B
Investment in Marketable and Equity Securities, Total	-448B	-1,150B	-362B	-431B	122B
Other Investing Activities, Total	529B	348B	704B	560B	-676B
Cash from Investing	-5,349B	-9,229B	-13,170B	-13,663B	-12,471B
Long-Term Debt Issued, Total	5,661B	5,322B	13,166B	10,443B	23,576B
Total Debt Issued	5,661B	5,322B	13,166B	10,443B	23,576B
Long-Term Debt Repaid, Total	-5,106B	-4,822B	-8,117B	-8,621B	-18,198B
Total Debt Repaid	-5,106B	-4,822B	-8,117B	-8,621B	-18,198B
Issuance of Common Stock	8.84B	257B	-	-	-
Repurchase of Common Stock	-	-	-	-	-
Common Dividends Paid	-870B	-1,091B	-	-	-227B
Common & Preferred Stock Dividends Paid	-	-	-1,104B	-367B	-
Common & Preferred Stock Dividends Paid	-870B	-1,091B	-1,104B	-367B	-227B
Other Financing Activities, Total	429B	13,666B	2,212B	3,367B	1,092B
Cash from Financing	124B	13,332B	6,158B	4,821B	6,243B
Foreign Exchange Rate Adjustments	202B	64.53B	86.56B	576B	39.96B
Miscellaneous Cash Flow Adjustments	-	-	-23.88B	23.88B	-1.16B
Net Change in Cash	487B	4,737B	587B	-1,230B	2,045B
Supplemental Items
Cash Interest Paid	223B	304B	646B	939B	1,248B
Cash Income Tax Paid (Refund)	1,282B	1,707B	1,348B	660B	760B
Levered Free Cash Flow	-4,292B	-6,947B	-7,918B	-8,007B	-6,602B
Unlevered Free Cash Flow	-4,160B	-6,758B	-7,514B	-7,411B	-5,841B
Change In Net Working Capital	4,239B	3,477B	-103B	-2,122B	-3,035B
Net Debt Issued / Repaid	555B	500B	5,050B	1,822B	5,378B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	6.79	3.14	2.17	0.67	-0.3
Return on Total Capital	9.38	4.1	2.72	0.83	-0.37
Return On Equity %	17.4	7.15	5.27	-0.74	-3.78
Return on Common Equity	15.15	6.17	4.24	-4.69	-7.98
Margin Analysis
Gross Profit Margin %	26.3	19.25	15.9	15.41	17
SG&A Margin	12.95	11.72	10.46	13.75	14.39
EBITDA Margin %	18.44	12.32	11.66	11.4	10.43
EBITA Margin %	12.3	6.34	5.27	2.84	0.21
EBIT Margin %	11.78	5.78	4.58	1.87	-1.01
Income From Continuing Operations Margin %	8.57	4.19	3.74	-0.67	-3.91
Net Income Margin %	8.6	3.56	2.42	-1.41	-3.96
Net Avail. For Common Margin %	7.05	3.16	2.44	-3.14	-5.74
Normalized Net Income Margin	6.93	2.66	1.8	-1.68	-0.45
Levered Free Cash Flow Margin	-10.06	-13.4	-14.33	-16.37	-14.37
Unlevered Free Cash Flow Margin	-9.75	-13.03	-13.6	-15.15	-12.72
Asset Turnover
Asset Turnover	0.92	0.87	0.76	0.57	0.47
Fixed Assets Turnover	1.9	1.92	1.61	1.05	0.83
Receivables Turnover (Average Receivables)	7.3	7.5	7.11	6.02	6.17
Inventory Turnover (Average Inventory)	4.61	4.15	4.37	4.54	4.48
Short Term Liquidity
Current Ratio	1.35	1.8	1.57	1.32	1.09
Quick Ratio	0.74	1	0.97	0.81	0.7
Operating Cash Flow to Current Liabilities	0.37	0.03	0.41	0.33	0.32
Days Sales Outstanding (Average Receivables)	50	48.69	51.31	60.79	59.16
Days Outstanding Inventory (Average Inventory)	79.15	87.87	83.49	80.59	81.5
Average Days Payable Outstanding	38.23	34.1	36.84	34.94	35.17
Cash Conversion Cycle (Average Days)	90.91	102.46	97.96	106.44	105.49
Long Term Solvency
Total Debt/Equity	63.62	42.59	53.56	57.04	71.78
Total Debt / Total Capital	38.88	29.87	34.88	36.32	41.79
LT Debt/Equity	48.64	32.44	36.28	41.16	46.86
Long-Term Debt / Total Capital	29.73	22.75	23.62	26.21	27.28
Total Liabilities / Total Assets	54.61	44.86	47.15	48.86	53.39
EBIT / Interest Expense	23.82	9.88	3.91	0.96	-0.38
EBITDA / Interest Expense	37.28	21.09	9.95	5.85	3.94
(EBITDA - Capex) / Interest Expense	9.92	-6.65	-10.07	-9.47	-7.28
Total Debt / EBITDA	1.88	2.5	3.4	4.91	7.06
Net Debt / EBITDA	1.39	1.16	1.98	3.46	4.78
Total Debt / (EBITDA - Capex)	7.06	-7.92	-3.36	-3.03	-3.81
Net Debt / (EBITDA - Capex)	5.23	-3.69	-1.96	-2.14	-2.58
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	41.9	21.75	8.37	-11.46	-5.68
Gross Profit, 1 Yr. Growth %	77.58	-10.95	-10.9	-14.21	4.79
EBITDA, 1 Yr. Growth %	91.1	-18.76	1.8	-13.42	17.53
EBITA, 1 Yr. Growth %	164.24	-37.39	-10.49	-52.28	-179.36
EBIT, 1 Yr. Growth %	178.36	-40.4	-15.11	-63.75	-23
Earnings From Cont. Operations, 1 Yr. Growth %	526.09	-40.62	-3.53	-115.93	395.89
Net Income, 1 Yr. Growth %	615.87	-49.71	-27.5	-151.64	163.36
Normalized Net Income, 1 Yr. Growth %	391.25	-53.26	-26.92	-183.1	-73.4
Diluted EPS Before Extra, 1 Yr. Growth %	617.07	-51.44	-24.94	-213.83	68.28
Accounts Receivable, 1 Yr. Growth %	20.55	16.65	8.49	1.03	-17.65
Inventory, 1 Yr. Growth %	54.84	43.43	-21.09	-5.63	-7.57
Net Property, Plant and Equip., 1 Yr. Growth %	18.53	21.68	31.31	40.1	3.46
Total Assets, 1 Yr. Growth %	23.55	32.93	13.97	21.16	7.68
Tangible Book Value, 1 Yr. Growth %	22.03	49.25	-0.93	4.1	-1.1
Common Equity, 1 Yr. Growth %	20.26	44.98	2.36	3.39	-1.32
Cash From Operations, 1 Yr. Growth %	-5.67	-89.66	1.22K	-6.95	17.42
Capital Expenditures, 1 Yr. Growth %	4.3	45.6	54.17	12.77	-6.53
Levered Free Cash Flow, 1 Yr. Growth %	494.25	62.07	-	1.12	-26.11
Unlevered Free Cash Flow, 1 Yr. Growth %	595.21	62.66	-	-1.37	-29.98
Dividend Per Share, 1 Yr. Growth %	20	-16.67	-65	-71.43	100
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	24.88	31.36	-	-2.05	-8.82
Gross Profit, 2 Yr. CAGR %	54.71	25.73	-	-12.57	-5.73
EBITDA, 2 Yr. CAGR %	73.11	24.61	-	-6.12	-13.76
EBITA, 2 Yr. CAGR %	133.66	28.63	-	-34.64	-81.71
EBIT, 2 Yr. CAGR %	146.75	28.82	-	-44.53	-57.08
Earnings From Cont. Operations, 2 Yr. CAGR %	200.31	92.85	-	-60.8	-6.74
Net Income, 2 Yr. CAGR %	242.21	89.73	-	-38.81	16.62
Normalized Net Income, 2 Yr. CAGR %	174.79	51.56	-	-22.18	-54.05
Diluted EPS Before Extra, 2 Yr. CAGR %	201.32	97.55	-	-7.56	39.93
Accounts Receivable, 2 Yr. CAGR %	30.71	18.58	-	4.69	-8.79
Inventory, 2 Yr. CAGR %	28.28	49.02	-	-13.7	-6.61
Net Property, Plant and Equip., 2 Yr. CAGR %	14.5	20.09	-	35.64	20.39
Total Assets, 2 Yr. CAGR %	22.59	28.15	-	17.51	14.22
Tangible Book Value, 2 Yr. CAGR %	13.98	34.96	-	1.55	1.47
Common Equity, 2 Yr. CAGR %	12.95	32.04	-	2.87	1.01
Cash From Operations, 2 Yr. CAGR %	32.87	-68.76	-	250.78	4.52
Capital Expenditures, 2 Yr. CAGR %	-3.8	23.23	-	31.85	2.67
Levered Free Cash Flow, 2 Yr. CAGR %	24.39	210.15	-	-	-8.69
Unlevered Free Cash Flow, 2 Yr. CAGR %	25.37	236.07	-	-	-11.84
Dividend Per Share, 2 Yr. CAGR %	144.95	0	-	-68.38	-24.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	14.81	23.77	22.47	-	-3.42
Gross Profit, 3 Yr. CAGR %	28.01	28.68	11.65	-	-7.48
EBITDA, 3 Yr. CAGR %	28.69	34.53	16.52	-	-8.86
EBITA, 3 Yr. CAGR %	31.43	50.65	13.78	-	-68.94
EBIT, 3 Yr. CAGR %	30.79	53.68	12.04	-	-46.12
Earnings From Cont. Operations, 3 Yr. CAGR %	33.99	74.98	53.08	-	-5.68
Net Income, 3 Yr. CAGR %	35.58	80.58	37.68	-	-0.47
Normalized Net Income, 3 Yr. CAGR %	34.29	52.27	34.57	-	-46.42
Diluted EPS Before Extra, 3 Yr. CAGR %	26.54	70.33	48.25	-	13.69
Accounts Receivable, 3 Yr. CAGR %	13.39	25.85	15.12	-	-3.36
Inventory, 3 Yr. CAGR %	24.53	33.14	20.56	-	-11.71
Net Property, Plant and Equip., 3 Yr. CAGR %	20.77	16.85	23.72	-	23.93
Total Assets, 3 Yr. CAGR %	20.89	25.95	23.24	-	14.13
Tangible Book Value, 3 Yr. CAGR %	8.05	24.7	21.74	-	0.66
Common Equity, 3 Yr. CAGR %	8.29	22.75	21.3	-	1.46
Cash From Operations, 3 Yr. CAGR %	37.38	-43.27	8.87	-	143.56
Capital Expenditures, 3 Yr. CAGR %	11.02	10.45	32.78	-	17.57
Levered Free Cash Flow, 3 Yr. CAGR %	38.11	35.81	79.61	-	-2.11
Unlevered Free Cash Flow, 3 Yr. CAGR %	39.13	36.68	82.2	-	-5.18
Dividend Per Share, 3 Yr. CAGR %	25.99	71	-29.53	-	-41.52
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	15.6	15.08	14.41	12.33	8.85
Gross Profit, 5 Yr. CAGR %	22.52	12.41	10.44	9.97	4.33
EBITDA, 5 Yr. CAGR %	18.77	8.27	11.79	16.27	3.09
EBITA, 5 Yr. CAGR %	20.73	1.9	4.74	7.66	-45.27
EBIT, 5 Yr. CAGR %	20.33	0.46	2.4	2.12	-23.73
Earnings From Cont. Operations, 5 Yr. CAGR %	23.33	1.43	6.34	-4.08	25.21
Net Income, 5 Yr. CAGR %	23.43	-1.05	-1.9	17.13	28.83
Normalized Net Income, 5 Yr. CAGR %	22.18	-3.33	-4.05	16.01	-19.07
Diluted EPS Before Extra, 5 Yr. CAGR %	17.27	-3.7	-2.01	35.73	44.31
Accounts Receivable, 5 Yr. CAGR %	12.57	10.86	13.03	16.91	4.88
Inventory, 5 Yr. CAGR %	22.81	28.79	16.93	11.94	8.86
Net Property, Plant and Equip., 5 Yr. CAGR %	20.29	21.48	22.99	24.03	22.38
Total Assets, 5 Yr. CAGR %	20.07	22.11	21.76	22.5	19.55
Tangible Book Value, 5 Yr. CAGR %	7.88	14.66	13.28	14.86	13.18
Common Equity, 5 Yr. CAGR %	9.25	14.23	13.51	14.38	12.73
Cash From Operations, 5 Yr. CAGR %	16.97	-29.1	28.81	17.57	7.11
Capital Expenditures, 5 Yr. CAGR %	32.79	30.13	25.16	18.56	19.8
Levered Free Cash Flow, 5 Yr. CAGR %	48.64	52.52	37.19	23.62	55.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	45.43	49.52	37.22	22.87	57.72
Dividend Per Share, 5 Yr. CAGR %	-	10.76	-10.22	-12.94	-27.52